organic compounds
6-Fluoro-4-oxochroman-2-carboxylic acid
aKey Laboratory of Drug Targeting of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, People's Republic of China
*Correspondence e-mail: wyong@scu.edu.cn
The title compound, C10H7FO4, is an intermediate in the synthesis of the drug Fidarestat, (2S,4S)-2-aminoformyl-6-fluoro-spiro[chroman-4,4′-imidazolidine]-2′,5′-dione. The dihydropyranone ring adopts an with the asymmetric C atom in the flap position. In the crystal, the molecules are linked into zigzag chains along [100] by O—H⋯O hydrogen bonds and C—H⋯π interactions involving the benzene ring.
Related literature
Fidarestat, which shows strong inhibition to aldose reductases, is used to treat complications of diabetes, see: Mealy (1996); Mitsuru et al. (2000). For related structures, see: Kurono et al. (1989); Yamaguchi et al. (1994).
Experimental
Crystal data
|
Refinement
|
Data collection: CrystalClear (Rigaku/MSC, 2005); cell CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: SHELXL97.
Supporting information
https://doi.org/10.1107/S1600536809054555/ci2987sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536809054555/ci2987Isup2.hkl
To a stirred solution of (2S,4R)-2-(1',2'-Dihydroxyethyl)-6-fluoro-chroman-4-one (10.7 g, 0.05 mol) in 300 ml of anhydrous benzene at room temperature was added lead tetraacetate (22.2 g, 0.05 mol). After 30 min, the solution was filtered and the filtrate was evaporated in vacuum to the residue. To the solution of 2% aqueous silver nitrate (651 ml, 0.07 mol) was added 5% aqueous sodium hydroxide (120 ml, 0.16 mol), and then generated the black precipitate immediately. To this stirred solution at room temperature was added, dropwise over 5 min, 4% ammonia water (520 ml, 0.16 mol). The black precipitate disappeared. The residue described above was dissolved in small amounts of THF and then added in this stirred solution at 323–333 K. After 10 min, the solution was filtered, and the precipitate was washed with water. The filtrate was acidified to pH 1 with 6 N aqueous hydrochloric acid, and then extracted with ethyl acetate. The organic extracts were dried (MgSO4) and then concentrated under reduced pressure. The residue was mixed with a mixture of ethanol and water, and left to crystallize 8.7 g (83%) of 6-Fluoro- 4-oxochroman-2-carboxylic acid. Colourless crystals suitable for X-ray analysis were obtained by slow evaporation in ethanol at room temperature.
H atoms were positioned geometrically (O-H = 0.84 and C-H = 0.95–1.00 Å) and refined using a riding model, with Uiso(H) = 1.2Ueq(C) and 1.5Ueq(O). In the absence of significant
Friedel pairs were merged prior to the final Nine reflections that were affected by the beamstop were discarded.The optically active (S)-6-fluoro-4-oxochroman-2-carboxylic acid is a key intermediate for synthesizing Fidarestat which shows strong inhibition to aldose reductases to cure incurable complications of diabetes (Mitsuru et al., 2000; Mealy, 1996). Our interests in synthesizing Fidarestat prompted us to develop an efficient methodology for synthesizing (S)-6-fluoro-4-oxochroman-2-carboxylic acid. In our synthetic work, we obtained the title compound, which is similar to those reported in the literature (Kurono et al., 1989; Yamaguchi et al., 1994). Its
is reported here.The dihydropyranone ring adopts an π interactions (Table 1) involving the benzene ring.
with the asymmetric C atom in the flap position (Fig. 1). The molecules are linked into zigzag chains along the [100] by O—H···O hydrogen bonds and C—H···Fidarestat, which shows strong inhibition to aldose reductases, is used to treat complications of diabetes, see: Mealy (1996); Mitsuru et al. (2000). For related structures, see: Kurono et al. (1989); Yamaguchi et al. (1994).
Data collection: CrystalClear (Rigaku/MSC, 2005); cell
CrystalClear (Rigaku/MSC, 2005); data reduction: CrystalClear (Rigaku/MSC, 2005); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: SHELXL97 (Sheldrick, 2008).Fig. 1. The molecular structure of the title compound, with displacement ellipsoids drawn at the 50% probability level. |
C10H7FO4 | F(000) = 432 |
Mr = 210.16 | Dx = 1.602 Mg m−3 |
Orthorhombic, P212121 | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: P 2ac 2ab | Cell parameters from 3184 reflections |
a = 5.3472 (11) Å | θ = 1.6–27.8° |
b = 12.748 (3) Å | µ = 0.14 mm−1 |
c = 12.785 (3) Å | T = 113 K |
V = 871.5 (3) Å3 | Block, colourless |
Z = 4 | 0.28 × 0.23 × 0.22 mm |
Rigaku Saturn CCD area-detector diffractometer | 1212 independent reflections |
Radiation source: rotating anode | 1049 reflections with I > 2σ(I) |
Confocal monochromator | Rint = 0.045 |
Detector resolution: 7.31 pixels mm-1 | θmax = 27.9°, θmin = 2.3° |
ω and φ scans | h = −7→6 |
Absorption correction: multi-scan (ABSCOR; Higashi, 1995) | k = −16→16 |
Tmin = 0.962, Tmax = 0.970 | l = −16→16 |
8640 measured reflections |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.027 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.073 | H-atom parameters constrained |
S = 1.12 | w = 1/[σ2(Fo2) + (0.0448P)2] where P = (Fo2 + 2Fc2)/3 |
1212 reflections | (Δ/σ)max = 0.001 |
137 parameters | Δρmax = 0.17 e Å−3 |
0 restraints | Δρmin = −0.15 e Å−3 |
C10H7FO4 | V = 871.5 (3) Å3 |
Mr = 210.16 | Z = 4 |
Orthorhombic, P212121 | Mo Kα radiation |
a = 5.3472 (11) Å | µ = 0.14 mm−1 |
b = 12.748 (3) Å | T = 113 K |
c = 12.785 (3) Å | 0.28 × 0.23 × 0.22 mm |
Rigaku Saturn CCD area-detector diffractometer | 1212 independent reflections |
Absorption correction: multi-scan (ABSCOR; Higashi, 1995) | 1049 reflections with I > 2σ(I) |
Tmin = 0.962, Tmax = 0.970 | Rint = 0.045 |
8640 measured reflections |
R[F2 > 2σ(F2)] = 0.027 | 0 restraints |
wR(F2) = 0.073 | H-atom parameters constrained |
S = 1.12 | Δρmax = 0.17 e Å−3 |
1212 reflections | Δρmin = −0.15 e Å−3 |
137 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
F1 | 0.8260 (2) | 0.32440 (8) | 0.43315 (9) | 0.0336 (3) | |
O1 | 0.2480 (2) | 0.03466 (8) | 0.23160 (9) | 0.0189 (3) | |
O2 | 0.1188 (2) | 0.34646 (9) | 0.17373 (10) | 0.0230 (3) | |
O3 | 0.5538 (2) | 0.03536 (10) | 0.06321 (10) | 0.0230 (3) | |
O4 | 0.2609 (3) | 0.11076 (10) | −0.03716 (9) | 0.0250 (3) | |
H4 | 0.3799 | 0.1179 | −0.0795 | 0.037* | |
C1 | 0.6806 (3) | 0.25426 (12) | 0.38164 (13) | 0.0200 (4) | |
C2 | 0.5057 (3) | 0.29048 (13) | 0.31336 (12) | 0.0184 (4) | |
H2 | 0.4862 | 0.3636 | 0.3015 | 0.022* | |
C3 | 0.3547 (3) | 0.21751 (12) | 0.26079 (12) | 0.0152 (3) | |
C4 | 0.1561 (3) | 0.25266 (12) | 0.19024 (12) | 0.0154 (3) | |
C5 | −0.0026 (3) | 0.16808 (13) | 0.14292 (12) | 0.0175 (3) | |
H5A | −0.0588 | 0.1905 | 0.0726 | 0.021* | |
H5B | −0.1529 | 0.1573 | 0.1868 | 0.021* | |
C6 | 0.1404 (3) | 0.06506 (12) | 0.13377 (12) | 0.0167 (3) | |
H6 | 0.0182 | 0.0095 | 0.1130 | 0.020* | |
C7 | 0.3894 (3) | 0.10981 (12) | 0.27966 (12) | 0.0155 (4) | |
C8 | 0.5700 (3) | 0.07625 (13) | 0.35030 (12) | 0.0182 (4) | |
H8 | 0.5923 | 0.0034 | 0.3630 | 0.022* | |
C9 | 0.7161 (4) | 0.14813 (12) | 0.40169 (12) | 0.0200 (4) | |
H9 | 0.8396 | 0.1257 | 0.4502 | 0.024* | |
C10 | 0.3450 (3) | 0.06823 (12) | 0.05065 (13) | 0.0174 (3) |
U11 | U22 | U33 | U12 | U13 | U23 | |
F1 | 0.0418 (7) | 0.0231 (5) | 0.0358 (6) | −0.0017 (5) | −0.0248 (5) | −0.0041 (5) |
O1 | 0.0218 (6) | 0.0139 (5) | 0.0211 (5) | −0.0031 (5) | −0.0003 (5) | 0.0013 (4) |
O2 | 0.0246 (7) | 0.0158 (6) | 0.0287 (6) | 0.0020 (5) | −0.0091 (5) | 0.0024 (5) |
O3 | 0.0155 (6) | 0.0265 (6) | 0.0270 (6) | 0.0037 (5) | 0.0012 (5) | −0.0053 (5) |
O4 | 0.0189 (6) | 0.0340 (6) | 0.0221 (6) | −0.0007 (6) | 0.0050 (6) | 0.0024 (5) |
C1 | 0.0225 (10) | 0.0191 (8) | 0.0184 (7) | −0.0018 (7) | −0.0048 (7) | −0.0029 (7) |
C2 | 0.0226 (10) | 0.0146 (7) | 0.0181 (7) | 0.0007 (7) | −0.0026 (7) | −0.0004 (6) |
C3 | 0.0155 (8) | 0.0147 (7) | 0.0155 (7) | 0.0006 (6) | 0.0004 (6) | 0.0009 (6) |
C4 | 0.0137 (8) | 0.0165 (8) | 0.0161 (7) | 0.0007 (7) | 0.0018 (6) | −0.0007 (6) |
C5 | 0.0142 (8) | 0.0182 (8) | 0.0201 (8) | −0.0016 (7) | 0.0011 (6) | −0.0024 (6) |
C6 | 0.0151 (8) | 0.0149 (7) | 0.0201 (8) | −0.0027 (7) | 0.0004 (6) | −0.0013 (6) |
C7 | 0.0170 (9) | 0.0140 (7) | 0.0154 (7) | −0.0006 (7) | 0.0045 (7) | −0.0012 (6) |
C8 | 0.0226 (9) | 0.0137 (7) | 0.0181 (7) | 0.0049 (7) | 0.0033 (7) | 0.0035 (6) |
C9 | 0.0217 (9) | 0.0229 (8) | 0.0154 (7) | 0.0042 (7) | −0.0006 (7) | 0.0024 (6) |
C10 | 0.0174 (9) | 0.0133 (7) | 0.0214 (8) | −0.0041 (7) | 0.0010 (7) | −0.0048 (7) |
F1—C1 | 1.3557 (18) | C3—C4 | 1.464 (2) |
O1—C7 | 1.366 (2) | C4—C5 | 1.499 (2) |
O1—C6 | 1.4302 (19) | C5—C6 | 1.524 (2) |
O2—C4 | 1.2305 (19) | C5—H5A | 0.99 |
O3—C10 | 1.203 (2) | C5—H5B | 0.99 |
O4—C10 | 1.325 (2) | C6—C10 | 1.526 (2) |
O4—H4 | 0.84 | C6—H6 | 1.00 |
C1—C2 | 1.360 (2) | C7—C8 | 1.390 (2) |
C1—C9 | 1.390 (2) | C8—C9 | 1.372 (2) |
C2—C3 | 1.403 (2) | C8—H8 | 0.95 |
C2—H2 | 0.95 | C9—H9 | 0.95 |
C3—C7 | 1.406 (2) | ||
C7—O1—C6 | 115.20 (12) | H5A—C5—H5B | 108.0 |
C10—O4—H4 | 109.5 | O1—C6—C5 | 111.60 (12) |
F1—C1—C2 | 118.84 (14) | O1—C6—C10 | 109.14 (14) |
F1—C1—C9 | 118.29 (15) | C5—C6—C10 | 112.98 (13) |
C2—C1—C9 | 122.87 (16) | O1—C6—H6 | 107.6 |
C1—C2—C3 | 118.56 (15) | C5—C6—H6 | 107.6 |
C1—C2—H2 | 120.7 | C10—C6—H6 | 107.6 |
C3—C2—H2 | 120.7 | O1—C7—C8 | 117.44 (14) |
C2—C3—C7 | 119.28 (15) | O1—C7—C3 | 122.30 (15) |
C2—C3—C4 | 120.64 (14) | C8—C7—C3 | 120.25 (15) |
C7—C3—C4 | 120.03 (14) | C9—C8—C7 | 120.09 (15) |
O2—C4—C3 | 121.39 (14) | C9—C8—H8 | 120.0 |
O2—C4—C5 | 122.54 (15) | C7—C8—H8 | 120.0 |
C3—C4—C5 | 116.04 (13) | C8—C9—C1 | 118.95 (16) |
C4—C5—C6 | 111.51 (13) | C8—C9—H9 | 120.5 |
C4—C5—H5A | 109.3 | C1—C9—H9 | 120.5 |
C6—C5—H5A | 109.3 | O3—C10—O4 | 124.77 (16) |
C4—C5—H5B | 109.3 | O3—C10—C6 | 124.27 (15) |
C6—C5—H5B | 109.3 | O4—C10—C6 | 110.96 (14) |
F1—C1—C2—C3 | −179.60 (15) | C6—O1—C7—C3 | 24.6 (2) |
C9—C1—C2—C3 | −0.1 (3) | C2—C3—C7—O1 | 179.64 (14) |
C1—C2—C3—C7 | −0.4 (2) | C4—C3—C7—O1 | 2.1 (2) |
C1—C2—C3—C4 | 177.15 (14) | C2—C3—C7—C8 | 0.5 (2) |
C2—C3—C4—O2 | 1.2 (2) | C4—C3—C7—C8 | −177.00 (14) |
C7—C3—C4—O2 | 178.73 (16) | O1—C7—C8—C9 | −179.41 (14) |
C2—C3—C4—C5 | −176.75 (14) | C3—C7—C8—C9 | −0.3 (2) |
C7—C3—C4—C5 | 0.8 (2) | C7—C8—C9—C1 | −0.2 (2) |
O2—C4—C5—C6 | 154.54 (16) | F1—C1—C9—C8 | 179.88 (15) |
C3—C4—C5—C6 | −27.50 (19) | C2—C1—C9—C8 | 0.3 (3) |
C7—O1—C6—C5 | −52.00 (18) | O1—C6—C10—O3 | 10.0 (2) |
C7—O1—C6—C10 | 73.59 (16) | C5—C6—C10—O3 | 134.74 (16) |
C4—C5—C6—O1 | 53.01 (17) | O1—C6—C10—O4 | −170.78 (12) |
C4—C5—C6—C10 | −70.43 (17) | C5—C6—C10—O4 | −46.00 (17) |
C6—O1—C7—C8 | −156.25 (14) |
D—H···A | D—H | H···A | D···A | D—H···A |
O4—H4···O2i | 0.84 | 1.81 | 2.6474 (19) | 171 |
C5—H5B···Cg1ii | 0.99 | 2.51 | 3.4521 (19) | 160 |
Symmetry codes: (i) x+1/2, −y+1/2, −z; (ii) x−1, y, z. |
Experimental details
Crystal data | |
Chemical formula | C10H7FO4 |
Mr | 210.16 |
Crystal system, space group | Orthorhombic, P212121 |
Temperature (K) | 113 |
a, b, c (Å) | 5.3472 (11), 12.748 (3), 12.785 (3) |
V (Å3) | 871.5 (3) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.14 |
Crystal size (mm) | 0.28 × 0.23 × 0.22 |
Data collection | |
Diffractometer | Rigaku Saturn CCD area-detector |
Absorption correction | Multi-scan (ABSCOR; Higashi, 1995) |
Tmin, Tmax | 0.962, 0.970 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 8640, 1212, 1049 |
Rint | 0.045 |
(sin θ/λ)max (Å−1) | 0.657 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.027, 0.073, 1.12 |
No. of reflections | 1212 |
No. of parameters | 137 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.17, −0.15 |
Computer programs: CrystalClear (Rigaku/MSC, 2005), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), ORTEP-3 (Farrugia, 1997).
D—H···A | D—H | H···A | D···A | D—H···A |
O4—H4···O2i | 0.84 | 1.81 | 2.6474 (19) | 171 |
C5—H5B···Cg1ii | 0.99 | 2.51 | 3.4521 (19) | 160 |
Symmetry codes: (i) x+1/2, −y+1/2, −z; (ii) x−1, y, z. |
References
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565. CrossRef IUCr Journals Google Scholar
Higashi, T. (1995). ABSCOR. Rigaku Corperation, Tokyo, Japan. Google Scholar
Kurono, M., Kondo, Y., Yamaguchi, T., Miura, K., Usui, T., Terada, N., Asano, K., Mizuno, K., Matsubara, A., Kato, N., Sawai, K., Unno, T., Ozawa, H. & Fukushima, M. (1989). US Patent No. 4861792. Google Scholar
Mealy, N. (1996). Drugs Future, 21, 261–265. CAS Google Scholar
Mitsuru, O., Yudiharu, M., Shigeru, S., Oka, M., Matsumoto, Y., Sugiyama, S., Tsuruta, N. & Matsushima, M. (2000). J. Med. Chem. 43, 2479–2483. Web of Science PubMed Google Scholar
Rigaku/MSC (2005). CrystalClear. Rigaku/MSC, The Woodlands, Texas, USA. Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Yamaguchi, T., Miura, K., Usui, T., Unno, R., Matsumoto, Y., Fukushima, M., Mizuno, K., Kondo, Y., Baba, Y. & Kurono, M. (1994). Arzneim. Forsch. 44, 344–348. CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
The optically active (S)-6-fluoro-4-oxochroman-2-carboxylic acid is a key intermediate for synthesizing Fidarestat which shows strong inhibition to aldose reductases to cure incurable complications of diabetes (Mitsuru et al., 2000; Mealy, 1996). Our interests in synthesizing Fidarestat prompted us to develop an efficient methodology for synthesizing (S)-6-fluoro-4-oxochroman-2-carboxylic acid. In our synthetic work, we obtained the title compound, which is similar to those reported in the literature (Kurono et al., 1989; Yamaguchi et al., 1994). Its crystal structure is reported here.
The dihydropyranone ring adopts an envelope conformation with the asymmetric C atom in the flap position (Fig. 1). The molecules are linked into zigzag chains along the [100] by O—H···O hydrogen bonds and C—H···π interactions (Table 1) involving the benzene ring.